Testing Inhaled Generics

New product-specific FDA guidance and USP monographs support the development of popular inhaled products. This article reviews their value in the rapidly growing generic sector.

This article is taken from Pharmaceutical Manufacturing and Packing Sourcer , December 2015, Innovations in Pharmaceutical Technology.

Download PDF

Training & Support

Find out more about the broad range of training opportunities and comprehensive support we offer customers

Training

We offer a range of training courses, presentations and seminars covering a wide range of topics Find out more

Servicing

A comprehensive range of both in-house and on-site product servicing options are available Find out more

Support

Our team of experienced technicians and engineers are on hand to help and advise Find out more

Downloads

Access the latest product brochures, whitepapers and other useful content

Find out more

First Name *

Last Name *

Email Address *

Organisation Name *

Message *

Please review our privacy policy so you understand how we collect and use your personal data.

Captcha

Testing Inhaled Generics

Establishing an Optimal Test Set-up for Delivered Dose Uniformity Testing for Nasal Drug Products

Improving Performance in Inhaled Therapeutics

Reducing Variability in the Inhaler Testing Environment

Better In Vivo Prediction from OINDP Testing: A Goal Worth Pursuing?

Improving the Utility of In Vitro Test Methods for Intranasal Drug Delivery

OINDPnews Q&A With Copley’s Clair Brooks on In Vitro Testing for LGWP MDI Reformulation